Peripheral arterial disease: medical care and prevention of complications (Q34714712)

4 August 2017

1 reference

title

Peripheral arterial disease: medical care and prevention of complications (English)

1 reference

4 August 2017

David L Dawson

1

1 reference

4 August 2017

William R Hiatt

series ordinal

2

1 reference

4 August 2017

Mark A Creager

series ordinal

3

1 reference

4 August 2017

Alan T Hirsch

series ordinal

4

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

published in

Preventive Cardiology

1 reference

4 August 2017

volume

5

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

119-130

1 reference

Presidential address: a team for the 21st century: the vascular center

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Peripheral arterial disease in the elderly: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Lower extremity arterial disease in elderly subjects with systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Factors affecting the diagnosis of peripheral vascular disease before vascular surgery referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

The epidemiology of peripheral arterial disease: importance of identifying the population at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Arteriosclerosis Obliterans: Review of 520 Cases with Special Reference to Pathogenic and Prognostic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Effects of colestipol-niacin therapy on human femoral atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

The use of statins: a case of misleading priorities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

The peripheral vascular consequences of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Conservative management of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

Duplex sonography of lower extremity arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2002.00558.X

10.1111/J.1520-037X.2002.00558.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference